Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Amicus Therapeutics Inc shares valued at $75,524 were sold by Campbell Bradley L on May 01 ’24. At $10.07 per share, Campbell Bradley L sold 7,500 shares. The insider’s holdings dropped to 886,654 shares worth approximately $8.3 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Campbell Bradley L sold 7,500 shares, netting a total of over 87,496 in proceeds. Following the sale of shares at $11.67 each, the insider now holds 886,654 shares.
Before that, MCGLYNN MARGARET G had sold 7,500 shares from its account. In a trade valued at $100,500, the Director traded Amicus Therapeutics Inc shares for $13.40 each. Upon closing the transaction, the insider’s holdings decreased to 7,500 shares, worth approximately $0.55 million.
As published in a research note from Guggenheim on May 14, 2024, Amicus Therapeutics Inc [FOLD] has been rated up from a Neutral to a Buy and the price target has been revised to $13. Analysts at Morgan Stanley upgraded the stock from ‘”an Equal-weight”‘ to ‘”an Overweight”‘ outlook in a report released in mid December. As of September 09, 2022, Morgan Stanley has initiated its “an Equal-weight” rating for FOLD.
Analyzing FOLD Stock Performance
During the last five days, there has been a drop of approximately -5.55%. Over the course of the year, Amicus Therapeutics Inc shares have dropped approximately -34.04%. Shares of the company reached a 52-week high of $14.53 on 01/02/24 and a 52-week low of $9.02 on 05/13/24. A 50-day SMA is recorded $10.57, while a 200-day SMA reached $11.81. Nevertheless, trading volume fell to 1.64 million shares from 3.17 million shares the previous day.
Support And Resistance Levels for Amicus Therapeutics Inc (FOLD)
According to the 24-hour chart, there is a support level at 9.27, which, if violated, would cause prices to drop to 9.17. In the upper region, resistance lies at 9.47. The next price resistance is at 9.57. RSI (Relative Strength Index) is 38.15 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.01, which suggests the price will decrease in the coming days. Percent R is at 67.31%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
